• Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Telegram
  • Koo
  • Youtube
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ

Tag: Mrna Vaccine

DCGI Approves Phase 2/3 Trials Of First mRNA Vaccine
DCGI Approves Phase 2/3 Trials Of First mRNA Vaccine

Gennova submitted the proposed Phase 2 and 3 study titled 'A Prospective, Multicentre, Randomised, Active-controlled, Observer-blind, Phase II study seamlessly followed by a Phase III study to evaluate the Safety, Tolerability, and Immunogenicity of the candidate HGCO19 (COVID-19 vaccine) in healthy subjects' which was approved by the office of the DCGI, CDSCO.

mRNA
DCGI Gives Nod To India's First Indigenous mRNA Vaccine For Human Trial

New Delhi: India’s first indigenous mRNA vaccine candidate has received approval from the Drug Controller General of India to initiate Phase I/II human clinical trial, the Ministry of Earth Sciences said on Friday. The novel mRNA vaccine candidate, HGCO19 has been developed by Gennova, a company based in Pune and supported with seed grant under […]

COVID-19-vaccine
COVID-19 Treatment: Moderna's Coronavirus Vaccine Shows Early Promise In Human Trial, Stock Soars

New York: In a ray of hope against Covid-19, an mRNA vaccine under human clinical trial by Massachusetts-bases biotechnology giant Moderna has shown promising results by generating an immune-system response in the body to fight coronavirus. mRNA-1273 is an mRNA vaccine against SARS-CoV-2 which was selected by Moderna in collaboration with investigators from the Vaccine […]

scrollToTop